Association for Innovation and Biomedical Research on Light and Image
PUBLICATION NAME
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
CHAD // Centre for Health Technology Assessment and Drug Research
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Journal of Clinical Pharmacy and Therapeutics 2014. DOI: 10.1111/jcpt.12148
2014
